[go: up one dir, main page]

MX2013011835A - Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas. - Google Patents

Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas.

Info

Publication number
MX2013011835A
MX2013011835A MX2013011835A MX2013011835A MX2013011835A MX 2013011835 A MX2013011835 A MX 2013011835A MX 2013011835 A MX2013011835 A MX 2013011835A MX 2013011835 A MX2013011835 A MX 2013011835A MX 2013011835 A MX2013011835 A MX 2013011835A
Authority
MX
Mexico
Prior art keywords
nutritional compositions
fatty acids
branched chain
chain fatty
wound healing
Prior art date
Application number
MX2013011835A
Other languages
English (en)
Inventor
Norman Alan Greenberg
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013011835A publication Critical patent/MX2013011835A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)

Abstract

Se proporcionan composiciones nutricionales para mejorar, tratar y/o prevenir diversas afecciones médicas y métodos para utilizar las mismas. Las afecciones médicas pueden incluir heridas, mucositis, entre otras. Las composiciones nutricionales incluyen ácidos grasos de cadena ramificada y pueden incluir otros ingredientes funcionales tales como, pero no limitados a probióticos, nucleótidos y aminoácidos. También se proporcionan métodos para administrar tales composiciones nutricionales a los individuos que necesiten de las mismas.
MX2013011835A 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas. MX2013011835A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161474452P 2011-04-12 2011-04-12
PCT/EP2012/056645 WO2012140118A1 (en) 2011-04-12 2012-04-12 Nutritional compositions including branched chain fatty acids for wound healing

Publications (1)

Publication Number Publication Date
MX2013011835A true MX2013011835A (es) 2013-11-01

Family

ID=45976923

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2013011835A MX2013011835A (es) 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas.
MX2013011834A MX2013011834A (es) 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada y metodos para utilizar las mismas.
MX2013011836A MX2013011836A (es) 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada y metodos para utilizar las mismas.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2013011834A MX2013011834A (es) 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada y metodos para utilizar las mismas.
MX2013011836A MX2013011836A (es) 2011-04-12 2012-04-12 Composiciones nutricionales que incluyen acidos grasos de cadena ramificada y metodos para utilizar las mismas.

Country Status (12)

Country Link
US (3) US20140037602A1 (es)
EP (3) EP2696867A1 (es)
JP (3) JP2014514304A (es)
CN (3) CN103458890A (es)
AU (3) AU2012241895A1 (es)
BR (3) BR112013026082A2 (es)
CA (3) CA2831341A1 (es)
MX (3) MX2013011835A (es)
PH (3) PH12013501892A1 (es)
SG (3) SG193927A1 (es)
WO (3) WO2012140132A1 (es)
ZA (2) ZA201308469B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
ITMI20130476A1 (it) * 2013-03-28 2014-09-29 Novintethical Pharma Sagl Composizioni per il trattamento di disturbi gastro-intestinali a base di complessi di tannini con proteine
GB2516266A (en) * 2013-07-17 2015-01-21 Ziqian Jia A composition
CN103798596B (zh) * 2014-02-28 2015-04-22 青岛市中心医院 一种供心脑血管疾病患者食用的全营养配方食品
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
JP6693413B2 (ja) * 2014-04-30 2020-05-13 味の素株式会社 消化管障害を改善する組成物
GB201417016D0 (en) * 2014-09-26 2014-11-12 Micromass Ltd Accurate mobility chromatograms
EP3459540A1 (en) * 2014-11-24 2019-03-27 Entrinsic Health Solutions, Inc. Amino acid compositions for the treatment of symptoms of disease
CN104544454A (zh) * 2014-12-19 2015-04-29 渤海大学 一种海参肽营养粉及其制备方法
CN107106653A (zh) * 2015-01-23 2017-08-29 雀巢产品技术援助有限公司 可用于治疗ibd患者的营养组合物
US20160324904A1 (en) * 2015-05-05 2016-11-10 Ryozo Saito Supplement for improving immunotolerance, intestinal environment and intestinal tract barrier
US20180071237A1 (en) * 2015-05-05 2018-03-15 Ryozo Saito Treatment method for improving intestinal enviornment and intestinal tract barrier
JP6773269B2 (ja) * 2015-05-14 2020-10-21 プロフェッショナル ダイエテティクス エス．ピー．エー． 放射線療法および／または化学療法を受けている腫瘍患者における粘膜炎の治療における使用のためのアミノ酸を備える組成物
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
JP6964960B2 (ja) * 2015-11-13 2021-11-10 ニュートリー株式会社 術後の創傷部及び／又は吻合部の回復を促進するための栄養組成物
CA3004976C (en) * 2015-12-04 2025-05-06 Societe Des Produits Nestle S.A. Cocoa polyphenols and soluble dietary fiber for use in the treatment or prevention of disorders associated with above-normal granulocyte counts in tissue.
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
CN105901703B (zh) * 2016-04-19 2020-03-10 上海海洋大学 一种用于烧伤患者的海洋生物型肠内营养制剂
CN106036655A (zh) * 2016-06-21 2016-10-26 宋庆利 一种主食制品及其用途以及含其的含乳饮料的制备方法
CN106213522A (zh) * 2016-08-05 2016-12-14 郑家福 营养保健品
RU2762607C2 (ru) 2016-09-13 2021-12-21 Аллерган, Инк. Стабилизированные небелковые композиции клостридиального токсина
JP2018052890A (ja) * 2016-09-30 2018-04-05 ニュートリー株式会社 術後の創傷治癒過程における炎症期の創傷治癒を促進するための栄養組成物
JP6974460B2 (ja) * 2016-12-15 2021-12-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 鉄−カゼイン錯体及び酸化感受性化合物を含む粉末形態の組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN107519197A (zh) * 2017-01-13 2017-12-29 江苏西宏生物医药有限公司 一种果胶组合物
CA3050208A1 (en) * 2017-01-20 2018-07-26 Skintech Life Science Limited Combination therapy for treatment of skin diseases
JP2018172329A (ja) * 2017-03-31 2018-11-08 公立大学法人岩手県立大学 肉芽形成促進組成物
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
US11260088B2 (en) 2017-06-21 2022-03-01 Abbott Laboratories Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
WO2019038668A1 (en) 2017-08-21 2019-02-28 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
KR102406166B1 (ko) * 2017-08-25 2022-06-10 강릉원주대학교산학협력단 아무르불가사리 지방산을 유효성분으로 포함하는 면역 증강용 조성물
MX2020002314A (es) 2017-08-30 2020-10-05 Shawn TALBOTT Suplementos nutricionales que afectan el equilibrio del eje intestino-cerebro y el bienestar mental.
CN107982513A (zh) * 2017-11-29 2018-05-04 北京艾沃森科技有限公司 一种盐藻地龙蛋白复方保健品及其制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
RU2677861C1 (ru) * 2018-05-11 2019-01-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство на основе березовых термированных опилок для лечения кожно-мышечных ран у сельскохозяйственных животных
CN108782764B (zh) * 2018-05-18 2022-01-11 石家庄君乐宝乳业有限公司 预防结肠炎的婴幼儿奶粉及其制备方法
US20210308196A1 (en) * 2018-06-01 2021-10-07 Evolve Biosystems, Inc. Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US12226433B2 (en) 2018-08-06 2025-02-18 The Johns Hopkins University Treatment of irritable bowel syndrome with molybdenum
AU2019328475B2 (en) 2018-08-29 2023-02-16 Dsm Ip Assets B.V. Formulations for improving gut health
NL2021737B1 (en) * 2018-10-01 2020-05-07 Nutricia Nv Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
WO2020132296A1 (en) * 2018-12-20 2020-06-25 Pantheryx, Inc. Medical nutrition product composition for acute diarrhea
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
CA3153409A1 (en) * 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of nutritional supplementation affecting microbiome metabolism
CN110742266B (zh) * 2019-11-11 2022-11-01 江南大学 一种辅助调节肠道免疫功能的全营养配方食品
CN111000042A (zh) * 2019-12-31 2020-04-14 福建天马科技集团股份有限公司 一种加州鲈鱼淡水养殖专用饲料，及其投喂用设备
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用
CN113637603B (zh) * 2021-07-12 2023-07-25 南京大学 一种肠道乳杆菌及其应用
EP4395756A1 (en) * 2021-08-31 2024-07-10 Institut National de la Santé et de la Recherche Médicale (INSERM) Use of branched chain fatty acids (bcfas) for the treatment of intestinal inflammation
CN115606691B (zh) * 2022-12-19 2023-07-11 中国农业科学院北京畜牧兽医研究所 生物素作为奶牛饲料添加剂中的用途
CN115969957B (zh) * 2022-12-21 2023-07-11 浙江佰穗莱生命健康科技有限公司 一种炎性肠病复合益生菌制剂及其制备方法
CN116121154B (zh) * 2023-04-10 2023-06-27 四川厌氧生物科技有限责任公司 一种乳明串珠菌及其应用
CN118892555B (zh) * 2024-07-08 2025-09-05 武汉大学 一种基于运动芽孢杆菌的口服纳米粒子及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56154414A (en) * 1980-04-30 1981-11-30 Tsuruhara Seiyaku Kk Antiulcerative containing fatty acid or its derivative
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
DE69133442T2 (de) 1990-07-13 2006-01-12 Gropep Ltd., Thebarton Wachstumsfördernder wirkstoff
FR2705234B1 (fr) * 1993-05-19 1995-08-04 Geffard Michel Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
US6333041B1 (en) * 1998-03-02 2001-12-25 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
CN1108796C (zh) * 1998-10-16 2003-05-21 杨振华 一种抗癌物质的应用及其生产方法
CA2444470A1 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US7129366B2 (en) 2001-08-03 2006-10-31 Yang's Biochem Co. Ltd. Group of a novel anti-cancer compounds with specific structure
CA2530437C (en) * 2003-06-23 2011-11-15 Nestec S.A. Nutritional formula for optimal gut barrier function
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US8636982B2 (en) * 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
CN101801200B (zh) * 2007-09-17 2014-10-29 康奈尔大学 用于预防或治疗胃肠病症的支链脂肪酸

Also Published As

Publication number Publication date
BR112013026032A2 (pt) 2016-12-20
PH12013501903A1 (en) 2013-11-25
MX2013011834A (es) 2014-02-11
EP2696868A1 (en) 2014-02-19
PH12013501892A1 (en) 2013-10-14
CN103458890A (zh) 2013-12-18
ZA201308469B (en) 2015-08-26
BR112013026082A2 (pt) 2019-09-24
CN103458888A (zh) 2013-12-18
WO2012140132A1 (en) 2012-10-18
JP2014510775A (ja) 2014-05-01
ZA201308478B (en) 2015-08-26
JP2014514304A (ja) 2014-06-19
SG193926A1 (en) 2013-11-29
US20140037601A1 (en) 2014-02-06
AU2012241814A1 (en) 2013-10-03
AU2012241895A1 (en) 2013-10-03
WO2012140133A1 (en) 2012-10-18
US20140037603A1 (en) 2014-02-06
US20140037602A1 (en) 2014-02-06
EP2696867A1 (en) 2014-02-19
SG193928A1 (en) 2013-11-29
WO2012140118A1 (en) 2012-10-18
PH12013501877A1 (en) 2019-10-07
EP2696866A1 (en) 2014-02-19
CA2831679A1 (en) 2012-10-18
CN103458889A (zh) 2013-12-18
SG193927A1 (en) 2013-11-29
CA2830970A1 (en) 2012-10-18
MX2013011836A (es) 2014-02-11
CA2831341A1 (en) 2012-10-18
AU2012241815A1 (en) 2013-09-26
BR112013026114A2 (pt) 2016-12-27
JP2014511871A (ja) 2014-05-19

Similar Documents

Publication Publication Date Title
PH12013501892A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MX387817B (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
BR112014008700A2 (pt) composições úteis no tratamento de nefropatia e processos para preparação das mesmas
IN2012DN02645A (es)
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
MX373650B (es) Triheptanoina para el tratamiento de la deficiencia del transportador de glucosa 1.
MX2020009677A (es) Composiciones preparadas de aves de corral y metodos de su uso.
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
PH12013502563A1 (en) Dha and epa in the reduction of oxidative stress
SG11201804192SA (en) Composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
MX2012002165A (es) Acidos grasos modificados con silicona, metodo de preparacion y su uso de los mismos.
IN2014DN09240A (es)
MX2017000878A (es) Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre.
WO2014031982A3 (en) Methods and compositions for treating pain
MX2012007158A (es) Derivados de peroxidos de dibenzoilo, metodo de preparacion de los mismos, composiciones cosmeticas o dermatologicas que los contienen.
BR112014015193A2 (pt) composição enriquecida com glicoproteína como um aditivo para alimento e/ou ração e/ou como um agente terapêutico